What is Hyster-Yale's earnings per share (EPS)?

Hyster-Yale (HY) reported diluted earnings per share of $-3.40 for fiscal year 2025. This represents a -142.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Hyster-Yale Financials

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Hyster-Yale (HY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 27/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Hyster-Yale has an operating margin of -0.6%, meaning the company retains $-1 of operating profit per $100 of revenue. This below-average margin results in a low score of 21/100, suggesting thin profitability after operating expenses. This is down from 5.7% the prior year.

Growth

Hyster-Yale's revenue declined 12.5% year-over-year, from $4.3B to $3.8B. This contraction results in a growth score of 12/100.

Leverage

Hyster-Yale carries a low D/E ratio of 1.00, meaning only $1.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 82/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Hyster-Yale's current ratio of 1.34 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow

While Hyster-Yale generated $86.1M in operating cash flow, capex of $62.5M consumed most of it, leaving $23.6M in free cash flow. This results in a low score of 27/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Hyster-Yale generates a -12.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 29.9% the prior year.

Piotroski F-Score Weak

2/9

Hyster-Yale passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

-1.43x

For every $1 of reported earnings, Hyster-Yale generates $-1.43 in operating cash flow ($86.1M OCF vs -$60.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-0.7x

Hyster-Yale earns $-0.7 in operating income for every $1 of interest expense (-$22.1M vs $31.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.8B

YoY-12.5%

5Y CAGR+6.0%

10Y CAGR+3.9%

Hyster-Yale generated $3.8B in revenue in fiscal year 2025. This represents a decrease of 12.5% from the prior year.

EBITDA

$23.7M

YoY-91.9%

5Y CAGR-23.9%

10Y CAGR-15.8%

Hyster-Yale's EBITDA was $23.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 91.9% from the prior year.

Net Income

-$60.1M

YoY-142.2%

Hyster-Yale reported -$60.1M in net income in fiscal year 2025. This represents a decrease of 142.2% from the prior year.

EPS (Diluted)

$-3.40

YoY-142.3%

Hyster-Yale earned $-3.40 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 142.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$23.6M

YoY-80.8%

5Y CAGR-27.2%

10Y CAGR-5.8%

Hyster-Yale generated $23.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 80.8% from the prior year.

Cash & Debt

$123.2M

YoY+27.5%

5Y CAGR-4.0%

10Y CAGR-2.3%

Hyster-Yale held $123.2M in cash against $473.4M in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.43

YoY+4.0%

5Y CAGR+2.4%

10Y CAGR+2.4%

Hyster-Yale paid $1.43 per share in dividends in fiscal year 2025. This represents an increase of 4.0% from the prior year.

Shares Outstanding

N/A

Margins & Returns

Gross Margin

16.8%

YoY-4.0pp

5Y CAGR+0.2pp

10Y CAGR+0.1pp

Hyster-Yale's gross margin was 16.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 4.0 percentage points from the prior year.

Operating Margin

-0.6%

YoY-6.3pp

5Y CAGR-2.4pp

10Y CAGR-4.6pp

Hyster-Yale's operating margin was -0.6% in fiscal year 2025, reflecting core business profitability. This is down 6.3 percentage points from the prior year.

Net Margin

-1.6%

YoY-4.9pp

5Y CAGR-2.9pp

10Y CAGR-4.5pp

Hyster-Yale's net profit margin was -1.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.9 percentage points from the prior year.

Return on Equity

-12.7%

YoY-42.7pp

5Y CAGR-18.7pp

10Y CAGR-28.9pp

Hyster-Yale's ROE was -12.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 42.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$137.2M

YoY+1.0%

5Y CAGR+6.4%

10Y CAGR+4.5%

Hyster-Yale invested $137.2M in research and development in fiscal year 2025. This represents an increase of 1.0% from the prior year.

Share Buybacks

-$4.5M

YoY+67.9%

Hyster-Yale spent -$4.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 67.9% from the prior year.

Capital Expenditures

$62.5M

YoY+30.8%

5Y CAGR+3.9%

10Y CAGR+3.0%

Hyster-Yale invested $62.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 30.8% from the prior year.

HY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.8B-12.5%	$4.3B+4.6%	$4.1B+16.1%	$3.5B+15.4%	$3.1B+9.4%	$2.8B
Cost of Revenue	$3.1B-8.1%	$3.4B+2.4%	$3.3B+7.0%	$3.1B+14.8%	$2.7B+15.6%	$2.3B
Gross Profit	$632.8M-29.3%	$895.5M+14.0%	$785.6M+81.1%	$433.9M+19.4%	$363.4M-21.9%	$465.4M
R&D Expenses	$137.2M+1.0%	$135.9M+13.5%	$119.7M+18.9%	$100.7M-7.0%	$108.3M+7.8%	$100.5M
SG&A Expenses	$616.5M-1.8%	$628.1M+8.9%	$576.9M+22.0%	$473.0M+5.1%	$450.1M+8.3%	$415.5M
Operating Income	-$22.1M-109.0%	$244.8M+17.3%	$208.7M+633.8%	-$39.1M+74.3%	-$152.3M-405.2%	$49.9M
Interest Expense	$31.2M-7.7%	$33.8M-9.4%	$37.3M+31.3%	$28.4M+83.2%	$15.5M+13.1%	$13.7M
Income Tax	$15.1M-79.8%	$74.8M+41.4%	$52.9M+475.0%	$9.2M-67.5%	$28.3M+664.9%	$3.7M
Net Income	-$60.1M-142.2%	$142.3M+13.0%	$125.9M+269.9%	-$74.1M+57.2%	-$173.0M-566.3%	$37.1M
EPS (Diluted)	$-3.40-142.3%	$8.04+11.0%	$7.24+265.3%	$-4.38+57.4%	$-10.29-565.6%	$2.21

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$923.2M-5.7%	$979.1M+2.4%	$956.6M+5.1%	$910.4M-14.7%	$1.1B+5.1%	$1.0B-13.0%	$1.2B+10.6%	$1.1B
Cost of Revenue	$792.2M-3.8%	$823.2M+4.4%	$788.4M+7.6%	$732.7M-14.8%	$859.9M+4.5%	$823.2M-9.4%	$908.8M+10.7%	$820.8M
Gross Profit	$131.0M-16.0%	$155.9M-7.3%	$168.2M-5.3%	$177.7M-14.4%	$207.6M+7.6%	$192.9M-25.6%	$259.3M+10.0%	$235.7M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$146.7M-3.9%	$152.6M-5.2%	$161.0M+3.1%	$156.2M+1.5%	$153.9M-3.0%	$158.6M-3.1%	$163.7M+7.8%	$151.9M
Operating Income	-$37.2M-1717.4%	$2.3M+127.1%	-$8.5M-139.9%	$21.3M-34.1%	$32.3M-2.4%	$33.1M-65.4%	$95.6M+14.1%	$83.8M
Interest Expense	$7.6M-5.0%	$8.0M+1.3%	$7.9M+2.6%	$7.7M0.0%	$7.7M-8.3%	$8.4M-4.5%	$8.8M-1.1%	$8.9M
Income Tax	$9.7M+434.5%	-$2.9M-1550.0%	$200K-97.5%	$8.1M-39.1%	$13.3M+29.1%	$10.3M-60.5%	$26.1M+4.0%	$25.1M
Net Income	-$52.5M-2182.6%	-$2.3M+83.5%	-$13.9M-261.6%	$8.6M-16.5%	$10.3M-40.1%	$17.2M-72.8%	$63.3M+22.9%	$51.5M
EPS (Diluted)	N/A	$-0.13+83.5%	$-0.79-264.6%	$0.48	N/A	$0.97-72.9%	$3.58+22.2%	$2.93

HY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$2.0B-0.4%	$2.0B-2.4%	$2.1B+2.6%	$2.0B+2.8%	$2.0B+5.9%	$1.9B
Current Assets	$1.3B-6.0%	$1.4B-3.8%	$1.5B+2.2%	$1.5B+8.1%	$1.4B+19.5%	$1.1B
Cash & Equivalents	$123.2M+27.5%	$96.6M+22.6%	$78.8M+33.6%	$59.0M-9.9%	$65.5M-56.7%	$151.4M
Inventory	$634.3M-15.9%	$754.3M-7.5%	$815.7M+2.0%	$799.5M+2.4%	$781.0M+53.3%	$509.4M
Accounts Receivable	$489.6M+0.2%	$488.4M-1.8%	$497.5M-5.0%	$523.6M+14.5%	$457.4M+11.0%	$412.1M
Goodwill	$55.7M+2.0%	$54.6M+2.4%	$53.3M+3.9%	$51.3M-9.2%	$56.5M-50.7%	$114.7M
Total Liabilities	$1.5B-0.4%	$1.5B-8.2%	$1.7B-7.2%	$1.8B+13.5%	$1.6B+31.3%	$1.2B
Current Liabilities	$1.0B-5.3%	$1.1B-13.2%	$1.2B-9.3%	$1.3B+21.6%	$1.1B+46.1%	$755.9M
Long-Term Debt	$473.4M+95.7%	$241.9M+0.2%	$241.3M-9.6%	$267.0M+2.0%	$261.7M+27.0%	$206.1M
Total Equity	$472.0M-0.7%	$475.1M+21.9%	$389.9M+90.8%	$204.4M-42.8%	$357.1M-42.1%	$616.9M
Retained Earnings	$289.1M-22.8%	$374.6M+46.2%	$256.3M+67.8%	$152.7M-38.6%	$248.6M-43.9%	$443.2M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$2.0B-1.9%	$2.1B-0.7%	$2.1B+1.0%	$2.1B+1.3%	$2.0B-6.6%	$2.2B+2.7%	$2.1B-0.1%	$2.1B
Current Assets	$1.3B-6.7%	$1.4B-0.9%	$1.5B+0.1%	$1.5B+1.5%	$1.4B-8.1%	$1.6B+2.0%	$1.5B+0.2%	$1.5B
Cash & Equivalents	$123.2M+73.3%	$71.1M+6.3%	$66.9M-13.3%	$77.2M-20.1%	$96.6M+27.8%	$75.6M+13.7%	$66.5M+6.9%	$62.2M
Inventory	$634.3M-14.3%	$740.3M-4.7%	$776.6M+0.5%	$772.7M+2.4%	$754.3M-11.8%	$855.3M+8.2%	$790.7M-6.1%	$841.9M
Accounts Receivable	$489.6M-6.0%	$520.6M+1.7%	$512.1M+1.2%	$506.1M+3.6%	$488.4M-10.0%	$542.5M-6.3%	$578.7M+11.2%	$520.5M
Goodwill	$55.7M+0.4%	$55.5M+0.2%	$55.4M+8.2%	$51.2M-6.2%	$54.6M-6.2%	$58.2M+12.8%	$51.6M-0.8%	$52.0M
Total Liabilities	$1.5B+1.5%	$1.5B-0.4%	$1.5B-0.9%	$1.5B-0.6%	$1.5B-5.4%	$1.6B-0.6%	$1.6B-3.3%	$1.7B
Current Liabilities	$1.0B-3.4%	$1.0B-0.5%	$1.0B-1.1%	$1.1B-0.4%	$1.1B-7.9%	$1.1B-2.0%	$1.2B-4.0%	$1.2B
Long-Term Debt	$473.4M+6.4%	$444.9M-1.2%	$450.2M+85.6%	$242.6M+0.3%	$241.9M-45.4%	$443.2M-6.9%	$475.8M+6.2%	$448.1M
Total Equity	$472.0M-11.9%	$536.0M-1.6%	$544.7M+6.8%	$510.0M+7.3%	$475.1M-10.3%	$529.9M+13.8%	$465.7M+13.0%	$412.1M
Retained Earnings	$289.1M-16.9%	$348.1M-2.4%	$356.7M-5.4%	$377.0M+0.6%	$374.6M+1.1%	$370.4M+3.1%	$359.3M+18.9%	$302.1M

HY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$86.1M-49.6%	$170.7M+13.3%	$150.7M+271.2%	$40.6M+116.0%	-$253.5M-251.9%	$166.9M
Capital Expenditures	$62.5M+30.8%	$47.8M+35.0%	$35.4M+22.9%	$28.8M-35.0%	$44.3M-14.3%	$51.7M
Free Cash Flow	$23.6M-80.8%	$122.9M+6.6%	$115.3M+877.1%	$11.8M+104.0%	-$297.8M-358.5%	$115.2M
Investing Cash Flow	-$62.7M-31.7%	-$47.6M-38.0%	-$34.5M+2.5%	-$35.4M-44.5%	-$24.5M+43.9%	-$43.7M
Financing Cash Flow	-$800K+99.2%	-$100.1M+0.4%	-$100.5M-822.0%	-$10.9M-105.6%	$193.6M+576.8%	-$40.6M
Dividends Paid	$25.4M+5.8%	$24.0M+7.6%	$22.3M+2.3%	$21.8M+0.9%	$21.6M+1.4%	$21.3M
Share Buybacks	-$4.5M+67.9%	-$14.0M	$0	$0	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$56.5M+52.3%	$37.1M+28.4%	$28.9M+179.4%	-$36.4M-145.1%	$80.7M+15.1%	$70.1M+2904.0%	-$2.5M-111.2%	$22.4M
Capital Expenditures	$23.6M+62.8%	$14.5M+5.1%	$13.8M+30.2%	$10.6M-40.8%	$17.9M+75.5%	$10.2M-16.4%	$12.2M+62.7%	$7.5M
Free Cash Flow	$32.9M+45.6%	$22.6M+49.7%	$15.1M+132.1%	-$47.0M-174.8%	$62.8M+4.8%	$59.9M+507.5%	-$14.7M-198.7%	$14.9M
Investing Cash Flow	-$22.9M-61.3%	-$14.2M+7.2%	-$15.3M-48.5%	-$10.3M+39.1%	-$16.9M-40.8%	-$12.0M-2.6%	-$11.7M-67.1%	-$7.0M
Financing Cash Flow	$17.6M+197.2%	-$18.1M+30.9%	-$26.2M-201.2%	$25.9M+168.3%	-$37.9M+25.4%	-$50.8M-366.0%	$19.1M+162.6%	-$30.5M
Dividends Paid	$6.5M+3.2%	$6.3M-1.6%	$6.4M+3.2%	$6.2M+1.6%	$6.1M0.0%	$6.1M0.0%	$6.1M+7.0%	$5.7M
Share Buybacks	-$9.0M-9100.0%	$100K+200.0%	-$100K-102.2%	$4.5M+119.5%	-$23.1M	$0	$0-100.0%	$9.1M

HY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	16.8%-4.0pp	20.8%+1.7pp	19.1%+6.8pp	12.2%+0.4pp	11.8%-4.7pp	16.6%
Operating Margin	-0.6%-6.3pp	5.7%+0.6pp	5.1%+6.2pp	-1.1%+3.9pp	-5.0%-6.7pp	1.8%
Net Margin	-1.6%-4.9pp	3.3%+0.2pp	3.1%+5.1pp	-2.1%+3.5pp	-5.6%-6.9pp	1.3%
Return on Equity	-12.7%-42.7pp	29.9%-2.3pp	32.3%+68.5pp	-36.3%+12.2pp	-48.4%-54.5pp	6.0%
Return on Assets	-3.0%-10.0pp	7.0%+0.9pp	6.1%+9.7pp	-3.7%+5.1pp	-8.8%-10.8pp	2.0%
Current Ratio	1.34-0.0	1.35+0.1	1.22+0.1	1.09-0.1	1.22-0.3	1.49
Debt-to-Equity	1.00+0.5	0.51-0.1	0.62-0.7	1.31+0.6	0.73+0.4	0.33
FCF Margin	0.6%-2.2pp	2.9%+0.1pp	2.8%+2.5pp	0.3%+10.0pp	-9.7%-13.8pp	4.1%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	14.2%-1.7pp	15.9%-1.7pp	17.6%-1.9pp	19.5%+0.1pp	19.4%+0.5pp	19.0%-3.2pp	22.2%-0.1pp	22.3%
Operating Margin	-4.0%-4.3pp	0.2%+1.1pp	-0.9%-3.2pp	2.3%-0.7pp	3.0%-0.2pp	3.3%-4.9pp	8.2%+0.3pp	7.9%
Net Margin	-5.7%-5.5pp	-0.2%+1.2pp	-1.5%-2.4pp	0.9%-0.0pp	1.0%-0.7pp	1.7%-3.7pp	5.4%+0.5pp	4.9%
Return on Equity	-11.1%-10.7pp	-0.4%+2.1pp	-2.5%-4.2pp	1.7%-0.5pp	2.2%-1.1pp	3.3%-10.3pp	13.6%+1.1pp	12.5%
Return on Assets	-2.6%-2.5pp	-0.1%+0.6pp	-0.7%-1.1pp	0.4%-0.1pp	0.5%-0.3pp	0.8%-2.2pp	3.0%+0.6pp	2.4%
Current Ratio	1.34-0.0	1.390.0	1.40+0.0	1.38+0.0	1.350.0	1.36+0.1	1.31+0.1	1.25
Debt-to-Equity	1.00+0.2	0.830.0	0.83+0.4	0.48-0.0	0.51-0.3	0.84-0.2	1.02-0.1	1.09
FCF Margin	3.6%+1.3pp	2.3%+0.7pp	1.6%+6.7pp	-5.2%-11.0pp	5.9%-0.0pp	5.9%+7.2pp	-1.3%-2.7pp	1.4%

Similar Companies

Titan Intl TWI

$479.5M

Wabash Natl Corp WNC

$342.9M

Columbus Mckinnon Corp N Y CMCO

$400.9M

Manitowoc Co MTW

$421.9M

Astec Inds Inc ASTE

$1.3B

Frequently Asked Questions

What is Hyster-Yale's annual revenue?

Hyster-Yale (HY) reported $3.8B in total revenue for fiscal year 2025. This represents a -12.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hyster-Yale's revenue growing?

Hyster-Yale (HY) revenue declined by 12.5% year-over-year, from $4.3B to $3.8B in fiscal year 2025.

Is Hyster-Yale profitable?

No, Hyster-Yale (HY) reported a net income of -$60.1M in fiscal year 2025, with a net profit margin of -1.6%.

What is Hyster-Yale's EBITDA?

Hyster-Yale (HY) had EBITDA of $23.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Hyster-Yale have?

As of fiscal year 2025, Hyster-Yale (HY) had $123.2M in cash and equivalents against $473.4M in long-term debt.

What is Hyster-Yale's gross margin?

Hyster-Yale (HY) had a gross margin of 16.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Hyster-Yale's operating margin?

Hyster-Yale (HY) had an operating margin of -0.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Hyster-Yale's net profit margin?

Hyster-Yale (HY) had a net profit margin of -1.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Hyster-Yale pay dividends?

Yes, Hyster-Yale (HY) paid $1.43 per share in dividends during fiscal year 2025.

What is Hyster-Yale's return on equity (ROE)?

Hyster-Yale (HY) has a return on equity of -12.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Hyster-Yale's free cash flow?

Hyster-Yale (HY) generated $23.6M in free cash flow during fiscal year 2025. This represents a -80.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Hyster-Yale's operating cash flow?

Hyster-Yale (HY) generated $86.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Hyster-Yale's total assets?

Hyster-Yale (HY) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Hyster-Yale's capital expenditures?

Hyster-Yale (HY) invested $62.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Hyster-Yale spend on research and development?

Hyster-Yale (HY) invested $137.2M in research and development during fiscal year 2025.

Does Hyster-Yale buy back shares?

Yes, Hyster-Yale (HY) spent $4.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Hyster-Yale's current ratio?

Hyster-Yale (HY) had a current ratio of 1.34 as of fiscal year 2025, which is considered adequate.

What is Hyster-Yale's debt-to-equity ratio?

Hyster-Yale (HY) had a debt-to-equity ratio of 1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Hyster-Yale's return on assets (ROA)?

Hyster-Yale (HY) had a return on assets of -3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Hyster-Yale's Piotroski F-Score?

Hyster-Yale (HY) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Hyster-Yale's earnings high quality?

Hyster-Yale (HY) has an earnings quality ratio of -1.43x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Hyster-Yale cover its interest payments?

Hyster-Yale (HY) has an interest coverage ratio of -0.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Hyster-Yale?

Hyster-Yale (HY) scores 27 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.